Related Experiment Video
Updated: Jun 26, 2025

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
Published on: September 14, 2010
Degradation of TRIM32 is induced by RTA for Kaposi's sarcoma-associated herpesvirus lytic replication
Yulin Zhang1, Zhongwei Dong1, Feng Gu1
1MOE/NHC/CAMS Key Laboratory of Medical Molecular Virology, Shanghai Institute of Infections Disease and Biosecurity, Shanghai Frontiers Science Center of Pathogenic Microorganism and Infection, School of Basic Medical Science, Shanghai Medical College, Fudan University, Shanghai, China.
Abstract:
TRIM32 is often aberrantly expressed in many types of cancers. Kaposi's sarcoma-associated herpesvirus (KSHV) is linked with several human malignancies, including Kaposi's sarcoma and primary effusion lymphomas (PELs). Increasing evidence has demonstrated the crucial role of KSHV lytic replication in viral tumorigenesis. However, the role of TRIM32 in herpesvirus lytic replication remains unclear. Here, we reveal that the expression of TRIM32 is upregulated by KSHV in latency, and reactivation of KSHV lytic replication leads to the inhibition of TRIM32 in PEL cells. Strikingly, RTA, the master regulator of lytic replication, interacts with TRIM32 and dramatically promotes TRIM32 for degradation via the proteasome systems. Inhibition of TRIM32 induces cell apoptosis and in turn inhibits the proliferation and colony formation of KSHV-infected PEL cells and facilitates the reactivation of KSHV lytic replication and virion production. Thus, our data imply that the degradation of TRIM32 is vital for the lytic activation of KSHV and is a potential therapeutic target for KSHV-associated cancers.
Importance:
TRIM32 is associated with many cancers and viral infections; however, the role of TRIM32 in viral oncogenesis remains largely unknown. In this study, we found that the expression of TRIM32 is elevated by Kaposi's sarcoma-associated herpesvirus (KSHV) in latency, and RTA (the master regulator of lytic replication) induces TRIM32 for proteasome degradation upon viral lytic reactivation. This finding provides a potential therapeutic target for KSHV-associated cancers.
Insights
Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates TRIM32 during latency. Viral lytic replication triggers RTA to degrade TRIM32, promoting KSHV reactivation and potentially offering a therapeutic target for KSHV cancers.
Area of Science:
- Virology
- Oncology
- Molecular Biology
Background:
- Trimer interacting protein 32 (TRIM32) is frequently dysregulated in various cancers.
- Kaposi's sarcoma-associated herpesvirus (KSHV) is implicated in human malignancies, with its lytic replication playing a key role in tumorigenesis.
- The specific function of TRIM32 in herpesvirus replication and oncogenesis is not well understood.
Purpose of the Study:
- To investigate the role of TRIM32 in KSHV infection and replication.
- To elucidate the mechanism by which KSHV influences TRIM32 expression.
- To assess the therapeutic potential of targeting TRIM32 in KSHV-associated cancers.
Main Methods:
- Analysis of TRIM32 expression in KSHV-infected cells (Primary Effusion Lymphoma - PEL cells) during latency and lytic replication.
- Investigating the interaction between KSHV's Replication and Transcription Activator (RTA) and TRIM32.
- Utilizing proteasome inhibitors to study TRIM32 degradation pathways.
- Assessing the impact of TRIM32 inhibition on PEL cell proliferation, apoptosis, and KSHV lytic reactivation.
Main Results:
- TRIM32 expression is elevated by KSHV during latency.
- KSHV lytic replication reactivation leads to TRIM32 downregulation in PEL cells.
- KSHV RTA directly interacts with TRIM32 and promotes its proteasomal degradation.
- TRIM32 inhibition induces apoptosis, reduces proliferation, and enhances KSHV lytic replication and virion production.
Conclusions:
- TRIM32 degradation, mediated by KSHV RTA, is essential for KSHV lytic replication.
- Targeting TRIM32 degradation presents a potential therapeutic strategy for KSHV-associated cancers.
More Related Videos
Related Concept Videos
Restarting Stalled Replication Forks
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Retrovirus Life Cycles

